Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2007-10-29 Interim / Quarterly Rep…
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
2007年第三季度报告
Interim / Quarterly Report Classification · 95% confidence The document is titled '2007 年第三季度报告' which translates to '2007 Third Quarter Report'. It contains detailed financial data including consolidated and parent company balance sheets, profit and loss statements, and cash flow statements for the period ending September 30, 2007. The report includes management's statements on the authenticity of the data, explanations of significant changes in financial metrics, and notes on important events affecting the company. The financial data is substantive and comprehensive, covering a period shorter than a full fiscal year (specifically a quarter). The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of unaudited quarterly financial statements and detailed analysis aligns with the definition of an Interim / Quarterly Report (IR). Therefore, the document should be classified as an Interim / Quarterly Report (IR). 9M 2007
2007-10-29 Chinese
风险提示性公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from Shanghai Wangchunhua (Group) Co., Ltd. It is a risk warning announcement stating that there are no undisclosed major price-sensitive information or significant asset restructuring matters. The document is only 405 characters long and does not contain any financial statements or detailed report content. It is not a full report but a regulatory announcement to inform investors about the current status and risk. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and risk disclosure.
2007-10-21 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by Shanghai Wangchunhua (Group) Co., Ltd. It discusses the stock price drop over three trading days and confirms that there is no undisclosed material information affecting the stock price. It references compliance with Shanghai Stock Exchange listing rules and provides a risk warning to investors. The document is short (742 characters) and serves as a regulatory announcement about stock price behavior rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or audit information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2007-10-16 Chinese
风险提示性公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from Shanghai Wangchunhua (Group) Co., Ltd. It is a risk warning announcement stating that there are no undisclosed major matters affecting the stock price, such as equity transfers, private placements, debt restructuring, or asset reorganizations. The document is brief (443 characters) and does not contain financial statements or detailed financial data. It is not a full report but a regulatory disclosure to inform investors about the absence of undisclosed material information. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2007-10-07 Chinese
风险提示性公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from Shanghai Wangchunhua (Group) Co., Ltd. It is a risk warning announcement stating that there are no undisclosed major sensitive information affecting the stock price, including equity transfers, private placements, debt restructuring, business restructuring, asset disposals or injections. The document is brief (404 characters) and serves as a disclosure or regulatory announcement rather than a full report or detailed financial document. It does not contain financial statements, management discussion, or detailed data. It is not a report publication announcement since it does not mention any report being published or attached. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about the company's status and risk disclosures without fitting other specific categories.
2007-09-16 Chinese
风险提示性公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from Shanghai Wangchunhua (Group) Co., Ltd. It is a risk warning announcement stating that there are no undisclosed major price-sensitive matters or significant asset restructuring events. The text is brief (403 characters) and does not contain financial statements or detailed financial data. It is not a full report but a regulatory disclosure to inform investors about the absence of undisclosed material information. This fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2007-09-02 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.